Vaginal ring dysmenorrhea feasibility trial

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-002449-40

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To identify at least one dose of progestin/estrogen amongst the 4 active doses being tested, administered as a vaginal ring, that shows clinically relevant treatment efficacy in relief of primary dysmenorrhea, as demonstrated by a statistically significantly larger reduction (as compared to baseline) in mean menstrual cramping pain score compared to placebo.


Critère d'inclusion

  • This study will investigate the use of 4 doses of combined contraceptives (a progestin with an estrogen) in a vaginal ring dosage form for the treatment of dysmenorrhea (menstrual cramping pain). A placebo control arm will also be utilized